This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

  1. Home
  2. Professionals
  3. Kerry Shannon Burke
  1. Back
Kerry Burke
Kerry Shannon Burke
Partner
Washington +1 202 662 5297 kburke@cov.com Download V-card
View Less

Kerry Shannon Burke has more than fifteen years of experience helping public and private companies structure and execute capital markets and finance transactions. Ms. Burke specializes in assisting issuers, ranging from development stage ventures to large public companies, as well as underwriters and other institutional investors, with private and public debt and equity financings. Ms. Burke regularly advises on securities and general corporate matters, including periodic reporting under the Securities Exchange Act and on other securities law compliance issues.

Transactional

Representative Capital Markets Transactions

  • Pepco Holdings and its subsidiaries in over $9.6 billion of private and public securities offerings, including the issuance of first mortgage bonds, senior notes, “fading lien” bonds, tax-exempt bonds and common stock.
  • Eli Lilly in $3.2 billion of various debt offerings and a €2.1 billion Eurobond offering.
  • Avnet in $900 million of registered debt offerings.
  • Omeros Corporation in various common stock and pre-funded warrant offerings, including at-the-market facilities.
  • Salix Pharmaceuticals in a $750.0 million high yield bond offering.
  • A foreign gaming company in a U.S. offering of ordinary shares.
  • Various public company issuers, including Bristol-Myers Squibb, Eli Lilly and Pepco Holdings in debt tender offers and related consent solicitations.
  • XLHealth in a $240 million private placement to a private equity investor and in a preferred stock investment by venture capital investors.

Representative Finance Transactions

  • Avnet in its $1.25 billion senior unsecured credit facility and $900 million securitization facility.
  • A pharmaceutical company in its $10 billion unsecured credit facility.
  • Pepco Holdings and its subsidiaries in their significant finance matters, including syndicated and bilateral credit facilities, commercial paper programs, bridge acquisition facilities, a credit intermediation arrangement and various swap transactions.
  • SandRidge Energy in its $900 million secured (borrowing base) credit facility.
  • A private specialty pharmaceutical company in its senior secured credit facility.
  • Lenders in the refinancing of the senior secured credit facility for the Verizon Center.
  • Various emerging growth companies in bridge financings and in secured lines of credit.

Advisory

  • Various public companies in securities reporting and corporate governance matters.
  • Various public and private companies in derivatives transactions.
  • Various private funds with the investment adviser registration process, including drafting Form ADVs and compliance policies and procedures.
  • Various investment advisers with ongoing compliance advice, including on conflicts of interest, fees, custody, pay-to-play, performance advertising and OCIE examination issues.

Pro Bono

  • Counseled a large museum and research organization on outstanding debt instruments.
View Less
  • Washington DC Super Lawyers, Securities & Corporate Finance (2014-2015)
  • Legal 500 US, Finance - Capital Markets (2013-2014)

Practices

Industries

Education

Cambridge University, LL.M., 2001

  • First class honors

Boston University School of Law, J.D., 1998

  • Magna cum laude
  • Journal of Science and Technology Law, Managing Editor

Clarkson University, B.S., 1995

  • With honors

Bar Admissions

  • District of Columbia
  • Massachusetts